Biomarkers for early diagnosis, prognosis, patient stratification, or monitoring treatment response is increasing in demand with the focus on personalized medical treatment.

Protein biomarkers offer a significantly higher degree of differentiated information compared to genomic biomarkers. In addition, proteins represent the direct functionality which makes them essential in understanding disease pathology and associated biological processes.

Targeted protein screening by Olink panels offers a unique way of investigating a selected part of the proteome in the search for disease-specific biomarkers, within multiple areas such as immunology, cardiovascular disease, neurology, and oncology.